Nanotechnology for Diabetes Management

Amar ABDERRAHMANI (>119 papers, h-index: 28, 3008 citations) is Full Professor of Cell and Molecular Biology at University of Lille since 2011, and Honorary Senior Research Scientist at imperial College London. He was awarded with the Chair of Excellence from the National Research Agency in experimental diabetology in 2011. He has a long-standing experience in human and rodent islet beta cells, pathophysiology of diabetes and pharmacology.Sabine Szunerits is Full Professor of Chemistry at University of Lille. Her current research interests are in the area of materials science with emphasis on the development of novel nanostructures and approaches for biomedical applications as well as sensing related issues. She is co-author of more than 320 research publications, wrote 24 book chapters and has 7 patents. In 2018, she was awarded with the CNRS Silver Medal for her contribution in the fields of sensing and nanomedicine.

• Chemical Approaches for Beta-cell Biology;Epigenomics of Type 2 Diabetes;Optimizing the Current Type 2 Diabetes Antidiabetics with Nanotechnologies: Where Do We Stand?;Amyloidosis Inhibition and Detection of Human Islet Amyloid Polypeptide with Nanomaterials;Phytochemicals in the Management of Diabetes;Inhalation of Insulin for Diabetes Management;Microfluidic and Organ-on-a-chip-based Technologies for Diabetes Therapy and Research;3D Bioprinting of Islets;In Vivo Imaging of the Pancreas and Gut Hormone Receptors;Invasive and Implantable Glucose Sensors: Perspective for the Artificial Pancreas;Artificial Intelligence for Diabetes-related Complications: Eye as a Window to Systemic Health